Chapter 1. Next Generation RNA Sequencing (NGS) Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Next Generation RNA Sequencing (NGS) Market – Executive Summary
2.1 Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Next Generation RNA Sequencing (NGS) Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Next Generation RNA Sequencing (NGS) Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Next Generation RNA Sequencing (NGS) Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Next Generation RNA Sequencing (NGS) Market – By Technology
6.1 Introduction/Key Findings
6.2 Sequencing by Synthesis
6.3 Ion Semiconductor Sequencing
6.4 Nanopore Sequencing
6.5 Single-Molecule Real-Time Sequencing
6.6 Y-O-Y Growth trend Analysis By Technology
6.7 Absolute $ Opportunity Analysis By Technology, 2023-2030
Chapter 7. Next Generation RNA Sequencing (NGS) Market – By Application
7.1 Introduction/Key Findings
7.2 De Novo Transcriptome Assembly
7.3 Variant calling and Transcriptome Epigenetics
7.4 Small RNA-Sequencing
7.5 Expression Profiling Analysis
7.6 Y-O-Y Growth trend Analysis By Application
7.7 Absolute $ Opportunity Analysis By Application, 2023-2030
Chapter 8. Next Generation RNA Sequencing (NGS) Market – By Sample Source
8.1 Introduction/Key Findings
8.2 Environmental/Microbial
8.3 Animal
8.4 Plant
8.5 Human
8.6 Y-O-Y Growth trend Analysis By Sample Source
8.7 Absolute $ Opportunity Analysis By Sample Source, 2023-2030
Chapter 9. Next Generation RNA Sequencing (NGS) Market – By Product & Service
9.1 Introduction/Key Findings
9.2 Sample Preparation Products
9.3 RNA-Sequencing Services
9.4 RNA Sequencing Platforms & Consumables
9.5 Data Analysis, Storage, and Management
9.6 Y-O-Y Growth trend Analysis By Product & Service
9.7 Absolute $ Opportunity Analysis By Product & Service, 2023-2030
Chapter 10. Next Generation RNA Sequencing (NGS) Market – By End-User
10.1 Introduction/Key Findings
10.2 Hospitals & Clinics
10.3 Pharmaceutical & Biotechnology Companies
10.4 Research & Academia
10.5 Others
10.6 Y-O-Y Growth trend Analysis By End-User
10.7 Absolute $ Opportunity Analysis By End-User, 2023-2030
Chapter 11. Next Generation RNA Sequencing (NGS) Market, By Geography – Market Size, Forecast, Trends & Insights
11.1 North America
11.1.1 By Country
11.1.1.1 U.S.A.
11.1.1.2 Canada
11.1.1.3 Mexico
11.1.2 By Technology
11.1.2.1 By Application
11.1.3 By Sample Source
11.1.4 By End-User
11.1.5 Countries & Segments - Market Attractiveness Analysis
11.2 Europe
11.2.1 By Country
11.2.1.1 U.K
11.2.1.2 Germany
11.2.1.3 France
11.2.1.4 Italy
11.2.1.5 Spain
11.2.1.6 Rest of Europe
11.2.2 By Technology
11.2.3 By Application
11.2.4 By Sample Source
11.2.5 By Product & Service
11.2.6 By End-User
11.2.7 Countries & Segments - Market Attractiveness Analysis
11.3 Asia Pacific
11.3.1 By Country
11.3.1.1 China
11.3.1.2 Japan
11.3.1.3 South Korea
11.3.1.4 India
11.3.1.5 Australia & New Zealand
11.3.1.6 Rest of Asia-Pacific
11.3.2 By Technology
11.3.3 By Application
11.3.4 By Sample Source
11.3.5 By Product & Service
11.3.6 By End-User
11.3.7 Countries & Segments - Market Attractiveness Analysis
11.4 South America
11.4.1 By Country
11.4.1.1 Brazil
11.4.1.2 Argentina
11.4.1.3 Colombia
11.4.1.4 Chile
11.4.1.5 Rest of South America
11.4.2 By Technology
11.4.3 By Application
11.4.4 By Sample Source
11.4.5 By Product & Service
11.4.6 By End-User
11.4.7 Countries & Segments - Market Attractiveness Analysis
11.5 Middle East & Africa
11.5.1 By Country
11.5.1.1 United Arab Emirates (UAE)
11.5.1.2 Saudi Arabia
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 South Africa
11.5.1.6 Nigeria
11.5.1.7 Kenya
11.5.1.8 Egypt
11.5.1.9 Rest of MEA
11.5.2 By Technology
11.5.3 By Application
11.5.4 By Sample Source
11.5.5 By Product & Service
11.5.6 By End-User
11.5.7 Countries & Segments - Market Attractiveness Analysis
Chapter 12. Next Generation RNA Sequencing (NGS) Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
12.1 Genewiz
12.2 Illumina
12.3 Biocompare
12.4 Integrated DNA Technologies
12.5 Nucleome Informatics
12.6 Qiagen
12.7 Thermo Fisher Scientific
12.8 CD Genomics
12.9 BGI Genomics
12.10 Novogene
12.11 Eurofins Genomics
2850
5250
4500
1800
Frequently Asked Questions
Next Generation RNA Sequencing (NGS) Market was valued at USD 2.89 billion and is projected to reach a market size of USD 10.57 billion by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 17.6%.
The increasing demand for personalized medicine and Technological advancements in sequencing technologies are the market drivers of the Next Generation RNA Sequencing (NGS) market.
Environmental/Microbial, Animal, Plant, and Human, are the segments under the Next Generation RNA Sequencing (NGS) Market by sample source.
North America is the most dominant region for the Next Generation RNA Sequencing (NGS) Market.
Genewiz, Illumina and Biocompare are few of the leading players in the Next Generation RNA Sequencing (NGS) Market.